Skip to main content
    S

    Sight Sciences Inc (SGHT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $10.59
    -0.24 (-2.22%)

    Market Cap: $601.92M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sight Sciences Inc (SGHT) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Sight Sciences reported revenue of $77.36M for the fiscal year ended Dec 31, 2025, down 3.1% from the year before. That year, net income was -$38.43M with a net margin of -49.7%, operating cash flow was -$29.69M and free cash flow was -$29.92M. The quarter ended Sep 30, 2026 had revenue of $24.92M and net income of -$6.81M.

    Revenue and Margins

    The operating margin was -48.0% in the fiscal year ended Dec 2025, the highest of the 3 years shown with an operating margin. Over the 7 years to Dec 2025, revenue grew from $7.53M, a compound annual rate of 39.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$77.36M-3.1%86.2%-48.0%-49.7%
    Dec 2024$79.87M-1.5%85.5%-63.3%-64.5%
    Dec 2023$81.06M+13.6%85.3%-70.7%-68.5%
    Dec 2022$71.33M+45.7%82.7%-117.7%-120.9%
    Dec 2021$48.96M+77.1%82.4%-105.2%-128.6%
    Dec 2020$27.64M+18.4%66.7%-116.5%-125.5%
    Dec 2019$23.35M+210.1%72.0%-103.0%-110.8%
    Dec 2018$7.53MN/A69.0%-189.9%-189.8%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$77.36M$79.87M$81.06M$71.33M$48.96M$27.64M$23.35M$7.53M
    Cost of revenue$10.70M$11.58M$11.88M$12.36M$8.61M$9.21M$6.54M$2.34M
    Gross profit$66.67M$68.28M$69.17M$58.97M$40.35M$18.43M$16.80M$5.19M
    Research and development$14.61M$17.99M$17.56M$22.86M$15.63M$8.87M$8.12M$5.43M
    Operating income-$37.10M-$50.53M-$57.27M-$83.95M-$51.48M-$32.19M-$24.04M-$14.30M
    Net income-$38.43M-$51.51M-$55.55M-$86.24M-$62.96M-$34.69M-$25.87M-$14.29M
    EBITDA-$35.82M-$49.10M-$56.09M-$80.36MN/A-$31.13M-$23.47M-$14.23M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$24.92M$23.39M$19.70M$20.39M$19.91M$19.56M$17.51M$19.07M$20.16M$21.37M$19.27M$18.75M
    Gross profit$21.42M$21.37M$16.98M$17.79M$17.20M$16.59M$15.09M$16.56M$16.91M$18.34M$16.47M$15.98M
    Operating income-$6.13M-$3.89M-$12.41M-$3.67M-$7.91M-$11.67M-$13.86M-$11.93M-$11.23M-$12.65M-$14.72M-$11.11M
    Net income-$6.81M-$4.45M-$12.98M-$4.16M-$8.17M-$11.94M-$14.15M-$11.85M-$11.07M-$12.33M-$16.27M-$10.69M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $40.30M by $51.66M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$115.30M$142.84M$166.65M$213.07M$280.19M$72.81M$30.74M$8.09M
    Current assets$112.73M$139.77M$162.87M$209.68M$277.04M$70.63M$28.00M$7.16M
    Cash and equivalents$91.97M$120.36M$138.13M$185.00M$260.69M$61.51M$21.24M$4.24M
    Total liabilities$51.36M$55.32M$46.44M$53.00M$48.08M$44.32M$85.42M$37.06M
    Short-term debt$0$533.00K$2.22M$0$510.00K$395.00K$557.00KN/A
    Long-term debt$40.30M$39.36M$31.71M$33.31M$32.66M$31.95M$12.86MN/A
    Shareholder equity$63.94M$87.52M$120.22M$160.08M$232.11M-$88.85M-$54.68M-$28.96M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$104.95M$104.87M$109.70M$115.30M$116.26M$121.97M$129.68M$142.84M$143.60M$149.72M$155.56M$166.65M
    Total liabilities$55.81M$51.98M$55.80M$51.36M$51.97M$51.96M$52.05M$55.32M$48.64M$48.08M$46.35M$46.44M
    Cash and equivalents$77.40M$79.75M$84.96M$91.97M$92.37M$101.50M$108.77M$120.36M$118.56M$118.18M$127.28M$138.13M
    Shareholder equity$49.14M$52.89M$53.90M$63.94M$64.29M$70.01M$77.63M$87.52M$94.96M$101.64M$109.21M$120.22M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-$29.69M-$22.35M-$47.18M-$75.97M-$52.54M-$32.17M-$25.00M-$14.47M
    Capital expenditures$224.00K$385.00K$791.00K$970.00K$813.00K$953.00K$672.00K$570.00K
    Free cash flow-$29.92M-$22.74M-$47.98M-$76.94M-$53.35M-$33.13M-$25.67M-$15.04M
    Investing cash flow-$224.00K-$385.00K-$791.00K-$970.00K-$813.00K-$953.00K-$672.00K-$570.00K
    Financing cash flow$1.79M$4.96M$1.10M$1.25M$252.53M$73.40M$42.66M$12.20M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$2.40M-$5.66M-$7.03M-$1.83M-$8.72M-$7.54M-$11.61M-$3.46M$362.00K-$9.47M-$9.79M-$6.48M
    Capital expenditures$68.00K$19.00K$60.00K$156.00K$170.00K$210.00K$0$137.00K$51.00K$80.00K$117.00K$264.00K
    Free cash flow-$2.47M-$5.68M-$7.09M-$1.98M-$8.89M-$7.75M-$11.61M-$3.60M$311.00K-$9.55M-$9.90M-$6.75M
    Last 12 quarters

    Frequently Asked Questions About SGHT

    What is Sight Sciences' annual revenue?

    Sight Sciences reported revenue of $77.36M for the fiscal year ended Dec 31, 2025.

    How fast is Sight Sciences' revenue growing?

    Revenue was down 3.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 2.7%.

    Is Sight Sciences profitable?

    No. Sight Sciences reported net income of -$38.43M for the fiscal year ended Dec 31, 2025, with a net margin of -49.7%.

    How much free cash flow does SGHT generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$29.69M minus capital expenditures of $224.00K produced free cash flow of -$29.92M.

    How much debt does Sight Sciences have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $40.30M, short-term debt of $0 and cash and equivalents of $91.97M.